D James Surmeier Selected Research

D James Surmeier Research Topics

Disease

46	Parkinson Disease (Parkinson's Disease) 01/2022 - 06/2006
8	Dyskinesias (Dyskinesia) 01/2022 - 03/2009
7	Huntington Disease (Huntington's Disease) 10/2021 - 10/2007
5	Parkinsonian Disorders (Parkinsonism) 11/2021 - 10/2007
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 05/2009
3	Mitochondrial Diseases (Mitochondrial Disease) 12/2017 - 07/2012
2	Inflammation (Inflammations) 01/2020 - 01/2008
2	Schizophrenia (Dementia Praecox) 01/2018 - 03/2017
2	Intellectual Disability (Idiocy) 01/2018 - 12/2009
2	Hypertension (High Blood Pressure) 12/2010 - 01/2010
1	Disease Progression 01/2022
1	Pain (Aches) 12/2021
1	Neuralgia (Stump Neuralgia) 12/2021
1	Basal Ganglia Diseases (Basal Ganglia Disease) 10/2021
1	Synucleinopathies 01/2019
1	Autism Spectrum Disorder 01/2018
1	Neurodevelopmental Disorders 01/2018
1	Wounds and Injuries (Trauma) 03/2015
1	Fibrosis (Cirrhosis) 03/2015
1	Cicatrix (Scar) 03/2015
1	Chorea (Rheumatic Chorea) 07/2014
1	Plague (Bubonic Plague) 07/2014
1	Dizziness (Lightheadedness) 12/2010
1	Edema (Dropsy) 12/2010
1	Dystonia (Limb Dystonia) 10/2007
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 10/2007
1	Movement Disorders (Movement Disorder) 10/2007
1	Herpes Zoster 02/2005

Drug/Important Bio-Agent (IBA)

12	Dopamine (Intropin)FDA LinkGeneric 11/2021 - 06/2007
11	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 03/2009
11	CalciumIBA 01/2020 - 10/2007
6	SynucleinsIBA 01/2022 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2005
4	Isradipine (Dynacirc)FDA LinkGeneric 01/2022 - 03/2009
4	Oxidants (Oxidizing Agents)IBA 01/2020 - 01/2012
4	Cholinergic Agents (Cholinergics)IBA 01/2020 - 10/2007
2	Phosphotransferases (Kinase)IBA 10/2020 - 07/2012
2	alpha-SynucleinIBA 01/2020 - 01/2010
2	Muscarinic M4 ReceptorIBA 01/2016 - 11/2015
2	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 06/2013 - 01/2012
2	Pharmaceutical PreparationsIBA 08/2010 - 10/2007
2	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2007 - 06/2006
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021
1	Leucine (L-Leucine)FDA Link 10/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2019
1	PrionsIBA 10/2017
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 03/2017
1	Antipsychotic Agents (Antipsychotics)IBA 03/2017
1	Protein AggregatesIBA 01/2017
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2015
1	SodiumIBA 03/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2014
1	trkB ReceptorIBA 07/2014
1	Calcium Channels (Calcium Channel)IBA 06/2013
1	Sirolimus (Rapamycin)FDA Link 07/2012
1	5- iodo- 3- ((3,5- dibromo- 4- hydroxyphenyl)methylene)- 2- indolinoneIBA 07/2012
1	UbiquinoneIBA 07/2012
1	Oxidopamine (6 Hydroxydopamine)IBA 05/2012
1	1,4-dihydropyridine (dihydropyridine)IBA 12/2010
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2010
1	Mitochondrial Uncoupling ProteinsIBA 12/2010
1	Cocaine (Cocaine HCl)IBA 08/2010
1	DihydropyridinesIBA 01/2010
1	Histones (Histone)IBA 12/2009
1	Biological ProductsIBA 09/2009
1	Adenosine (Adenocard)FDA LinkGeneric 12/2008
1	Probenecid (Benemid)FDA LinkGeneric 01/2008
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2008
1	Glutamic Acid (Glutamate)FDA Link 01/2008
1	AutoreceptorsIBA 06/2006

Therapy/Procedure

5	Therapeutics 01/2022 - 09/2009
2	Rejuvenation 01/2010 - 06/2007
1	Analgesia 12/2021
1	Self Administration (Administration, Self) 10/2021
1	Occlusive Dressings (Occlusive Dressing) 03/2015
1	Drug Tapering 12/2010
1	Denervation 03/2009